C. Ola Landgren, Chief of the Division of Myeloma at University of Miami and Leader of Experimental Therapeutics Program at Sylvester Comprehensive Cancer Center, shared a post on X:
“Exciting ‘FLAGSHIP’ study opened at Sylvester Comprehensive Cancer Center’s Myeloma Institute in Miami!
Collaboration with Boston Gene for exact molecular sub-typing and personalized treatment strategies.
See here.“
Source: C. Ola Landgren/X